Research projects of oncgnostics GmbH

Current Projects

Mobile Diagnostic Systems for Social Diseases – MEDIKIT

Together with our partners IMMS (Erfurt), ALS (Jena) and Senova (Weimar), new diagnostic platforms are developed here for application in mobile diagnostics.

Here you can read the message about it on our homepage.

Duration: 01. April 2018 – 30. June 2021

The project of our master student Carolin Hoyer is supported by the state of Thuringia and funds from the European Social Fund of the European Union.

Duration: 01. April 2021 – 31. January 2022

The project of our PhD student Daria Meyer is supported by the state of Thuringia and funds from the European Social Fund of the European Union.

Duration: 01. January 2021 – 31. December 2022

Finished Projects (not complete)

According to the consulting guideline of the Free State of Thuringia, the oncgnostics GmbH receives funding to increase the performance and competitiveness through the consulting of Stefan Sandström (Manifestum AB), (intensive consulting and process support). The results and recommendations for action are recorded in a consultant report. The funding is provided by the European Social Fund and by the Free State of Thuringia.

Duration: 29. May 2020 – January 2021

ASSURER

At the InfectoGnostics research campus in Jena, five partners from industry and research are developing a new cancer test that will provide a reliable diagnosis. The German Federal Ministry of Education and Research supports the so-called ASSURER project in the funding initiative “KMU-NetC”.
Partners: BLINK AG, oncgnostics GmbH, biotechrabbit GmbH, Quantifoil Instruments GmbH and the Gynecological Clinic of the University Hospital Jena.

Here you can read the official press release of the BMBF.

Duration: 1. October 2017 – 29. February 2020

The project of our PhD student Carolin Dippmann was supported by the state of Thuringia and funds from the European Social Fund of the European Union.

Duration: 01. June 2017 – 31. May 2020

MIMOSE

oncgnostics GmbH is developing an automated diagnostic platform for the early detection of cervical cancer in collaboration with IMMS Erfurt.

The IMMS is developing the prototype of a system that is intended to provide laboratory medical staff with a fast and reliable on-site decision-making aid in the field of early cancer detection for the correct diagnosis.

Duration: 2015 – 2017

Funded by: German Federal Ministry for Economic Affairs and Energy based on a resolution of the German Bundestag (funding code: KF2534515CS4).